Subcategory Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Model Systems/Therapeutic Targets$24,115,793.04
Fiscal Year: 2010
  

Download 2010 Model Systems/Therapeutic Targets projects (EXCEL)
Animal models mimicking behaviors of ASD and those that are being used to develop or test new drug treatments, as well as cell lines used to discover new drug targets or to screen potential drug candidates, are included in this subcategory.
Graph: The subcategories for Question 4 illustrate the many approaches to treatments and interventions supported by autism research funders. The largest amount of funding supported projects to develop Model systems and therapeutic targets (35%), followed by research on Behavioral interventions (29%). Medical/Pharmacologic interventions received 16% of funding, classroom-based interventions (Educational) received 10% of funding, and Technology-based interventions and supports received 7% of funding. The subcategories with the smallest amounts of funding included Occupational, physical, and sensory-based (2%) and Complementary, dietary, and alternative (1%).
Note: Initial Sort is by Principal Investigator. Sorting by other columns is available by clicking on the desired column header.
Project Title Principal Investigator Strategic Plan Objective Institution
Modeling and pharmacologic treatment of autism spectrum disorders in Drosophila McDonald, Thomas Q4.S.B Albert Einstein College of Medicine of Yeshiva University
A mouse knock-in model for ENGRAILED 2 autism susceptibility Millonig, James Q4.S.B University of Medicine & Dentistry of New Jersey
16p11.2: defining the gene(s) responsible Mills, Alea Q4.S.B Cold Spring Harbor Laboratory
Novel models to define the genetic basis of autism Mills, Alea Q4.S.B Cold Spring Harbor Laboratory
Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes Moy, Sheryl Q4.S.B University of North Carolina at Chapel Hill
Characterization of a novel mouse model of restricted repetitive behaviors Moy, Sheryl Q4.S.B University of North Carolina at Chapel Hill
Interaction between MEF2 and MECP2 in the pathogenesis of autism spectrum disorders -2 Nakanishi, Nobuki Q4.S.B Burnham Institute
Systematic analysis of neural circuitry in mouse models of autism Osten, Pavel Q4.S.B Cold Spring Harbor Laboratory
Role of L-type calcium channels in hippocampal neuronal network activity Owen, Scott Q4.S.B Stanford University
Novel probiotic therapies for autism Patterson, Paul Q4.S.B California Institute of Technology
Neurogenetic model of social behavior heterogeneity in autism spectrum disorders Platt, Michael Q4.S.B Duke University
High-resolution diffusion tensor imaging in mouse models relevant to autism Poptani, Harish Q4.S.B University of Pennsylvania
Animal models of autism: Pathogenesis and treatment Powell, Craig Q4.S.B University of Texas Southwestern Medical Center
Novel genetic animal models of autism Powell, Craig Q4.S.B University of Texas Southwestern Medical Center
Neuroligin function in vivo: Implications for autism and mental retardation Powell, Craig Q4.S.B University of Texas Southwestern Medical Center
Role of a novel Wnt pathway in autism spectrum disorders Reichardt, Louis Q4.S.B University of California, San Francisco
A novel cell-based assay for autism research and drug discovery Restifo, Linda Q4.S.B University of Arizona
Novel, subtype selective potentiators of nicotinic acetycholine receptors Schulte, Marvin Q4.Other University of Alaska Fairbanks
Design & synthesis of novel CNS-active oxytocin and vasopressin receptor ligands Roberts, Edward Q4.Other The Scripps Research Institute